About Biomanufacturing & Fermentation
The Biomanufacturing & Fermentation category is part of the Synthetic Biology market map, tracking 12 companies building in this segment. DNA synthesis, biomanufacturing, lab automation, and computational biology programming biology like software. Curated by Hartmann Capital's venture research team.
Companies in Biomanufacturing & Fermentation
- Solugen — Series D, $600M
- LanzaTech — Public, $830M
- Genomatica — Series D, $440M
- Bolt Threads — Series E, $571M
- Resilience — Late Stage, $2B
- Culture Biosciences — Series C, $107M
- Synonym — Series A, $30M
- DMC Biotechnologies — Series B, $34M
- Lygos — Series B, $68M
- Antheia — Series C, $152M
- Conagen — Series C, $60M
- Manus Bio — Series B, $47M
Frequently Asked Questions
- What companies are in the Biomanufacturing & Fermentation category?
- The Biomanufacturing & Fermentation category includes 12 companies: Solugen, LanzaTech, Genomatica, Bolt Threads, Resilience, Culture Biosciences, Synonym, DMC Biotechnologies, Lygos, Antheia, Conagen, Manus Bio. This is part of the Synthetic Biology market map maintained by Hartmann Capital.
- How many Biomanufacturing & Fermentation startups are tracked?
- Hartmann Capital tracks 12 companies in the Biomanufacturing & Fermentation segment of the Synthetic Biology market map.
- What are the best funded Biomanufacturing & Fermentation companies?
- Top funded companies in Biomanufacturing & Fermentation include Resilience ($2000M), LanzaTech ($830M), Solugen ($600M), Bolt Threads ($571M), Genomatica ($440M). Browse the full list in the Synthetic Biology market map.
- How can I submit my startup?
- You can submit your startup for inclusion by visiting the submission page. Submissions are reviewed by Hartmann Capital's research team.